Literature DB >> 17890119

Enhanced mortality despite control of lung infection in mice aerogenically infected with a Mycobacterium tuberculosis mce1 operon mutant.

Patricia Lima1, Ben Sidders, Lisa Morici, Rachel Reader, Ryan Senaratne, Nicola Casali, Lee W Riley.   

Abstract

Mycobacterium tuberculosis causes a variety of host clinical outcomes. We previously showed that M. tuberculosis disrupted in an operon called mce1 proliferates unchecked in BALB/c mouse lungs. The observed outcome could be attributed either to the mutant bacterial burden or to the host immunopathologic response. To differentiate these possibilities, we studied the outcomes of infection in a mouse strain (C57BL/6) less susceptible to M. tuberculosis than BALB/c. We found that the mutant infection reached a plateau in the lungs at a rate similar to that of the wild type. All mice infected with the mutant, but only half of the groups of mice infected with the wild type or complemented strain, died by 40 weeks (p<0.05). At 12-21 weeks of infection, histological examination of the lungs of mice infected with the mutant showed a diffuse pattern of lymphocyte infiltration, while that of mice infected with the other strains exhibited a nodular cellular infiltration pattern. Surprisingly, the number of bacilli recovered from the lungs was similar in all three groups. These observations suggest that rather than the bacterial burden, products of the mce1 operon may directly or indirectly modulate the host immune response that is protective to both the tubercle bacilli and the host.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17890119      PMCID: PMC2894154          DOI: 10.1016/j.micinf.2007.05.020

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  17 in total

Review 1.  Mechanisms of latency in Mycobacterium tuberculosis.

Authors:  N M Parrish; J D Dick; W R Bishai
Journal:  Trends Microbiol       Date:  1998-03       Impact factor: 17.079

2.  Cross-reaction between mammalian cell entry (Mce) proteins of Mycobacterium tuberculosis.

Authors:  M Harboe; A Christensen; S Ahmad; G Ulvund; R E Harkness; A S Mustafa; H G Wiker
Journal:  Scand J Immunol       Date:  2002-12       Impact factor: 3.487

3.  Recombinant Mycobacterium tuberculosis protein associated with mammalian cell entry.

Authors:  S Chitale; S Ehrt; I Kawamura; T Fujimura; N Shimono; N Anand; S Lu; L Cohen-Gould; L W Riley
Journal:  Cell Microbiol       Date:  2001-04       Impact factor: 3.715

4.  Invasion activity of a Mycobacterium tuberculosis peptide presented by the Escherichia coli AIDA autotransporter.

Authors:  Nicola Casali; Marc Konieczny; M Alexander Schmidt; Lee W Riley
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

5.  Mycobacterium tuberculosis in chemokine receptor 2-deficient mice: influence of dose on disease progression.

Authors:  Holly M Scott; JoAnne L Flynn
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

6.  Analysis of the proteome of Mycobacterium tuberculosis in silico.

Authors:  F Tekaia; S V Gordon; T Garnier; R Brosch; B G Barrell; S T Cole
Journal:  Tuber Lung Dis       Date:  1999

7.  Hypervirulent mutant of Mycobacterium tuberculosis resulting from disruption of the mce1 operon.

Authors:  Nobuyuki Shimono; Lisa Morici; Nicola Casali; Sally Cantrell; Ben Sidders; Sabine Ehrt; Lee W Riley
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-08       Impact factor: 11.205

8.  Genetic requirements for mycobacterial survival during infection.

Authors:  Christopher M Sassetti; Eric J Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

9.  Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG.

Authors:  E L Nuermberger; T Yoshimatsu; S Tyagi; W R Bishai; J H Grosset
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

10.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

View more
  11 in total

1.  Vaccination of guinea pigs using mce operon mutants of Mycobacterium tuberculosis.

Authors:  Andrés Obregón-Henao; Crystal Shanley; María Verónica Bianco; Angel A Cataldi; Randall J Basaraba; Ian M Orme; Fabiana Bigi
Journal:  Vaccine       Date:  2011-04-22       Impact factor: 3.641

2.  An orphaned Mce-associated membrane protein of Mycobacterium tuberculosis is a virulence factor that stabilizes Mce transporters.

Authors:  Ellen Foot Perkowski; Brittany K Miller; Jessica R McCann; Jonathan Tabb Sullivan; Seidu Malik; Irving Coy Allen; Virginia Godfrey; Jennifer D Hayden; Miriam Braunstein
Journal:  Mol Microbiol       Date:  2016-02-05       Impact factor: 3.501

3.  Comparative metabolic profiling of mce1 operon mutant vs wild-type Mycobacterium tuberculosis strains.

Authors:  Adriano Queiroz; Daniel Medina-Cleghorn; Olivera Marjanovic; Daniel K Nomura; Lee W Riley
Journal:  Pathog Dis       Date:  2015-08-28       Impact factor: 3.166

4.  Molecular Cloning, Purification and Characterization of Mce1R of Mycobacterium tuberculosis.

Authors:  Dipanwita Maity; Rajasekhara Reddy Katreddy; Amitava Bandhu
Journal:  Mol Biotechnol       Date:  2021-01-09       Impact factor: 2.695

5.  Posttreatment reactivation of tuberculosis in mice caused by Mycobacterium tuberculosis disrupted in mce1R.

Authors:  Chan-Ick Cheigh; Ryan Senaratne; Yujiro Uchida; Nicola Casali; Lon V Kendall; Lee W Riley
Journal:  J Infect Dis       Date:  2010-09-01       Impact factor: 5.226

6.  Attenuation of Mycobacterium tuberculosis functionally disrupted in a fatty acyl-coenzyme A synthetase gene fadD5.

Authors:  Kathleen Y Dunphy; Ryan H Senaratne; Mamiko Masuzawa; Lon V Kendall; Lee W Riley
Journal:  J Infect Dis       Date:  2010-04-15       Impact factor: 5.226

7.  Genome-wide identification of Mycobacterium tuberculosis exported proteins with roles in intracellular growth.

Authors:  Jessica R McCann; Justin A McDonough; Jonathan Tabb Sullivan; Meghan E Feltcher; Miriam Braunstein
Journal:  J Bacteriol       Date:  2010-12-10       Impact factor: 3.490

Review 8.  Use of siRNA molecular beacons to detect and attenuate mycobacterial infection in macrophages.

Authors:  Remo George; Renata Cavalcante; Celso Carvalho; Elyana Marques; Jonathan B Waugh; M Tino Unlap
Journal:  World J Exp Med       Date:  2015-08-20

9.  The genetic requirements for fast and slow growth in mycobacteria.

Authors:  Dany J V Beste; Mateus Espasa; Bhushan Bonde; Andrzej M Kierzek; Graham R Stewart; Johnjoe McFadden
Journal:  PLoS One       Date:  2009-04-28       Impact factor: 3.240

10.  Differential in vivo expression of mycobacterial antigens in Mycobacterium tuberculosis infected lungs and lymph node tissues.

Authors:  Tehmina Mustafa; Nils Anders Leversen; Lisbet Sviland; Harald Gotten Wiker
Journal:  BMC Infect Dis       Date:  2014-10-03       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.